BLINCYTO 38.5 MCG 10 ML 1 FLK
BLINCYTO 38.5 MCG 10 ML 1 FLK
Quantity
Get it to United States within 10 working days with standard delivery.
Fast delivery to United States
Easy Returns & Exchanges
Ask About This Product
Condition : New
0
From UAE
To United States
in 5-10 days
Description
- Mechanism of Action: BLINCYTO (blinatumomab) is a medication used to treat certain types of leukemia. It works by binding to both CD19, a protein found on the surface of B cells, and CD3, a protein found on the surface of T cells. By bringing these cells close together, BLINCYTO helps activate the body’s immune response to attack and kill cancer cells.
- Benefits: The benefits of BLINCYTO include:
- Treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL) in adults and children.
- Induction of remission in patients with B-cell precursor ALL.
- Improvement in overall survival and relapse-free survival in certain patient populations.
- Dosage and Administration: BLINCYTO is administered intravenously (into a vein) as a continuous infusion. The dosage and administration schedule are determined by a healthcare professional based on factors such as the patient’s weight, overall health, and response to treatment.
- Suitability: BLINCYTO is indicated for specific types of leukemia and is typically prescribed by oncologists or hematologists. The suitability of BLINCYTO for an individual patient would be assessed by a healthcare professional based on factors such as the type and stage of leukemia and any other medical conditions the patient may have.
- Availability: BLINCYTO is available by prescription only and is typically obtained from hospitals, specialty pharmacies, or medical facilities where intravenous medications are administered.
- Pricing: Prices of BLINCYTO can vary between countries and regions. To obtain specific pricing information for BLINCYTO 38.5 MCG 10 ML 1 FLK in different countries, you would need to consult pharmaceutical databases, local pharmacies, or healthcare providers in those regions.